Yahoo
NSE - Free Realtime Quote INR

Sanofi India Limited (SANOFI.NS)

3,385.00 +35.20 (+1.05%)
As of 12:02:07 PM GMT+5:30. Market Open.
Dividend
SANOFI.NS announced a cash dividend of INR 75.00 with an ex-date of Nov. 5, 2026
Chart Range Bar
Loading chart for SANOFI.NS
  • Previous Close 3,349.80
  • Open 3,375.00
  • Bid 3,382.20 x --
  • Ask 3,384.80 x --
  • Day's Range 3,351.90 - 3,394.00
  • 52 Week Range 2,758.20 - 4,832.00
  • Volume 22,199
  • Avg. Volume 22,993
  • Market Cap (intraday) 77.959B
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) 21.39
  • EPS (TTM) 158.27
  • Earnings Date (est.) --
  • Forward Dividend & Yield 123.00 (3.67%)
  • Ex-Dividend Date Nov 5, 2026
  • 1y Target Est 4,339.67

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.

www.sanofi.com/en/india/investors

1,097

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SANOFI.NS
16.06%
S&P BSE SENSEX (^BSESN)
10.11%

1-Year Return

SANOFI.NS
27.11%
S&P BSE SENSEX (^BSESN)
8.78%

3-Year Return

SANOFI.NS
52.54%
S&P BSE SENSEX (^BSESN)
19.02%

5-Year Return

SANOFI.NS
47.10%
S&P BSE SENSEX (^BSESN)
28.16%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 4.92B
Earnings --
Profit Margin 0.00%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
1B
2B
3B
4B
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

3,520.00
4,339.67 Average
3,385.00 Current
5,550.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.01%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    18.22B

  • Net Income Avi to Common (ttm)

    3.64B

  • Diluted EPS (ttm)

    158.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.69B

  • Total Debt/Equity (mrq)

    1.78%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: